Impact of Diabetes, Insulin, and Metformin Use on the Outcome of Patients With Human Epidermal Growth Factor Receptor 2-Positive Primary Breast Cancer: Analysis From the ALTTO Phase III Randomized Trial.
about
Demographic Characteristics, Survival and Prognostic Factors of Early Breast Cancer Patients with Type 2 Diabetes Mellitus: A Hospital-Based Cohort StudyDrug Resistance Driven by Cancer Stem Cells and Their Niche.Metabolic coupling and the Reverse Warburg Effect in cancer: Implications for novel biomarker and anticancer agent development.Integrated Pharmacodynamic Analysis Identifies Two Metabolic Adaption Pathways to Metformin in Breast CancerDrug Repurposing of Metabolic Agents in Malignant GliomaPleiotropic Effects of Metformin on Cancer
P2860
Impact of Diabetes, Insulin, and Metformin Use on the Outcome of Patients With Human Epidermal Growth Factor Receptor 2-Positive Primary Breast Cancer: Analysis From the ALTTO Phase III Randomized Trial.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Impact of Diabetes, Insulin, a ...... TO Phase III Randomized Trial.
@en
Impact of Diabetes, Insulin, a ...... TO Phase III Randomized Trial.
@nl
type
label
Impact of Diabetes, Insulin, a ...... TO Phase III Randomized Trial.
@en
Impact of Diabetes, Insulin, a ...... TO Phase III Randomized Trial.
@nl
prefLabel
Impact of Diabetes, Insulin, a ...... TO Phase III Randomized Trial.
@en
Impact of Diabetes, Insulin, a ...... TO Phase III Randomized Trial.
@nl
P2093
P2860
P50
P356
P1476
Impact of Diabetes, Insulin, a ...... TTO Phase III Randomized Trial
@en
P2093
Alvaro Moreno-Aspitia
Amir Sonnenblick
Debora Fumagalli
Dominique Agbor-Tarh
Hatem A Azim
Ian Bradbury
Julie Gralow
Lyndsay Harris
Maccon Keane
Martine Piccart-Gebhart
P2860
P304
P356
10.1200/JCO.2016.69.7722
P407
P577
2017-03-13T00:00:00Z